Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 57, Issue 9, Pages 3707-3714Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm401685f
Keywords
-
Categories
Funding
- China National 12.5 Foundation [2011BAJ07B04]
- Open Foundations from the State Key Laboratory of Oral Diseases Sichuan University [SKLODSCUKF2012-03, SKLODSCUKF2012-04]
- National Natural Science Foundation of China [20972105]
Ask authors/readers for more resources
Drug-resistant bacterial infections and lack of available antibacterial agents in clinical practice are becoming serious risks to public health. We synthesized a new class of haloemodins by modifying a traditional Chinese medicine component, emodin. The novel haloemodin exerts strong inhibitory activity on bacterial topoisomerase I and DNA gyrase, and not on the topoisomerases of human origin. In principle, it shows remarkable antibacterial activities against laboratory and clinically isolated Gram-positive bacteria, including vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus. We further expanded its antibacterial spectrum into against Gram-negative bacteria with the assistance of polymyxin B nonapeptide, which helps haloemodin to penetrate through the bacterial outer membrane. Finally, the therapeutic effect of haloemodin in vivo was confirmed in curing S. aureus-induced keratitis on rabbit model. With distinctive structural difference from the antibiotics we used, the haloemodins are of value as promising antibacterial pharmacophore, especially for combat the infections caused by drug-resistant pathogens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available